Maternal anxiety is related to infant neurological condition, paternal anxiety is not

Hedwig K Kikkert1, Karin J Middelburg, Mijna Hadders-Algra

  • 1Dept. of Paediatrics, Developmental Neurology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, Groningen, The Netherlands.

Insights

Maternal anxiety is linked to poorer infant neurological development. This study found that higher maternal trait anxiety correlated with less optimal infant neurological condition around one year of age.

Area of Science:

  • Neuroscience
  • Developmental Psychology
  • Pediatrics

Background:

  • Parental anxiety and stress can impact infant neurological development.
  • Understanding these influences is crucial for early intervention strategies.

Purpose of the Study:

  • To investigate the association between parental anxiety/well-being and infant neurological development.
  • To explore these relationships approximately one year after birth.

Main Methods:

  • A longitudinal study of 206 parent-child dyads from a birth cohort.
  • Infant neurology assessed using the Touwen Infant Neurological Examination (TINE) and a developmental questionnaire.
  • Parental trait anxiety (State-Trait Anxiety Inventory) and well-being (General Health Questionnaire) were measured.

Main Results:

  • Maternal trait anxiety showed a significant association with less optimal infant neurological condition (r(s) = -0.19, p<0.01).
  • This association remained significant after adjusting for confounders.
  • Paternal trait anxiety and parental well-being were not significantly related to infant neurodevelopmental outcomes.

Conclusions:

  • Infants born to mothers with high trait anxiety exhibit increased vulnerability for suboptimal nervous system development.
  • Early programming of monoaminergic systems may mediate this association.
  • Further research should identify specific vulnerability windows for maternal anxiety effects.
Abstract

Related Concept Videos

Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Generalized Anxiety Disorder01:30

Generalized Anxiety Disorder

Generalized Anxiety Disorder (GAD) is a chronic condition characterized by excessive and uncontrollable worry that persists for at least six months, significantly interfering with daily functioning. Unlike situational anxiety, which arises in response to specific stressors, GAD often occurs without a clear cause. Individuals may experience disproportionate worry about work, health, or relationships. For instance, a person might continuously fear poor health despite normal medical evaluations or...
Anxiolytic Drugs: Benzodiazepines and Buspirone01:29

Anxiolytic Drugs: Benzodiazepines and Buspirone

Benzodiazepines are a class of anxiolytic drugs known for their rapid efficacy and high therapeutic-to-lethal dose ratio, but with a potential risk of drug dependence. These drugs are lipophilic, allowing for rapid absorption after oral administration, eventually reaching the central nervous system (CNS). Once in the CNS, benzodiazepines bind to the allosteric site of the GABAA receptor. This binding enhances the inhibitory effects of the neurotransmitter GABA. By doing so, they prevent...